Evaluating the use of lamotrigine to reduce mood lability and impulsive behaviors in adults with chronic and severe eating disorders

Erin E. Reilly1,2,3, Laura A. Berner4,2, Mary Ellen Trunko2, Terry Ann Schwartz2, Leslie K. Anderson2, Angeline Krueger2, Xinze Yu2, Joanna Y. Chen2,5, Anne Cusack2, Tiffany Nakamura2, Walter H. Kaye2
1Department of Psychiatry and Behavioral Sciences, University of California, San Francisco, USA
2Department of Psychiatry, UCSD Health Eating Disorders Center for Research and Treatment, University of California, San Diego, San Diego, USA
3Department of Psychology, Hofstra University, Hempstead, USA
4Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA
5Department of Psychology, Drexel University, Philadelphia, USA

Tóm tắt

Abstract Background Gold-standard psychological and pharmacological treatments for bulimic-spectrum eating disorders only result in remission for around 50% of patients; patients with affective lability and impulsivity represent a subgroup with particularly poor outcomes. Both dialectical behavior therapy (DBT), a treatment for emotion dysregulation, and lamotrigine, a mood stabilizer, have demonstrated promise for targeting affective lability and impulsivity; however, data exploring the combination of these interventions remain limited. Objective We followed a group of women with recurrent dysregulated eating behaviors (N = 62) throughout intensive DBT treatment and compared the symptom trajectory of those prescribed lamotrigine (n = 28) and those who were not (n = 34). Method Participants completed surveys every 2 weeks throughout treatment. Results Group analyses suggested that all participants self-reported decreases in emotional reactivity, negative urgency, and symptoms of borderline personality disorder (BPD). The lamotrigine group reported greater elevations in BPD symptoms at baseline, but demonstrated steeper decreases in emotion and behavioral dysregulation than the non-matched comparison group. Within-subject analyses suggested that within the lamotrigine group, subjects reported greater decreases in symptoms following prescription of lamotrigine. Conclusions Findings provide initial data suggesting that lamotrigine could be useful as an adjunctive treatment for patients with affective lability and impulsivity. Level of evidence IV, time series without randomization.

Từ khóa


Tài liệu tham khảo

Keel PK, Brown TA (2010) Update on course and outcome in eating disorders. Int J Eat Disord 43:195–204. https://doi.org/10.1002/eat.20810

Fichter MM, Quadflieg N, Rief W (1994) Course of multi-impulsive bulimia. Psychol Med 24:591–604. https://doi.org/10.1017/s0033291700027744

Corstorphine E, Waller G, Lawson R, Ganis C (2007) Trauma and multi-impulsivity in the eating disorders. Eat Behav 8:23–30. https://doi.org/10.1016/j.eatbeh.2004.08.009

Svirko E, Hawton K (2007) Self-injurious behavior and eating disorders: the extent and nature of the association. Suicide Life Threat Behav 37:409–421. https://doi.org/10.1521/suli.2007.37.4.409

Agras WS, Crow SJ, Halmi KA, Mitchell JE, Wilson GT, Kraemer HC (2000) Outcome predictors for the cognitive behavior treatment of bulimia nervosa: data from a multisite study. Am J Psychiatry 157:1302–1308. https://doi.org/10.1176/appi.ajp.157.8.1302

Favaro A, Santonastaso P (2000) Self-injurious behavior in anorexia nervosa. J Nerv Ment Dis 188:537–542. https://doi.org/10.1097/00005053-200008000-00010

Peake KJ, Limbert C, Whitehead L (2005) Gone, but not forgotten: an examination of the factors associated with dropping out from treatment of eating disorders. Eur Eat Disord Rev 13:330–337. https://doi.org/10.1002/erv.645

Helverskov JL, Clausen L, Mors O, Frydenberg M, Thomsen PH, Rokkedal K (2010) Trans-diagnostic outcome of eating disorders: a 30-month follow-up study of 629 patients. Eur Eat Disord Rev 18:453–463. https://doi.org/10.1002/erv.1025

Rossiter EM, Agras WS, Telch CF, Schneider JA (1993) Cluster B personality disorder characteristics predict outcome in the treatment of bulimia nervosa. Int J Eat Disord 13:349–357. https://doi.org/10.1002/1098-108X(199305)13:4%3c349::AID-EAT2260130403%3e3.0.CO;2-C

Vall E, Wade TD (2015) Predictors of treatment outcome in individuals with eating disorders: a systematic review and meta-analysis. Int J Eat Disord 48:946–971. https://doi.org/10.1002/eat.22411

Kliem S, Kröger C, Kosfelder J (2010) Dialectical behavior therapy for borderline personality disorder: a meta-analysis using mixed-effects modeling. J Consult Clin Psychol 78:936–951. https://doi.org/10.1037/a0021015

Linehan MM (2018) Cognitive-behavioral treatment of borderline personality disorder. Guilford Publications

Federici A, Wisniewski L, Ben-Porath D (2012) Description of an intensive dialectical behavior therapy program for multidiagnostic clients with eating disorders. J Couns Dev 90:330–338. https://doi.org/10.1002/j.1556-6676.2012.00041.x

Wisniewski L, Kelly E (2003) The application of dialectical behavior therapy to the treatment of eating disorders. Cogn Behav Pract 10:131–138. https://doi.org/10.1016/S1077-7229(03)80021-4

Coker S, Vize C, Wade T, Cooper PJ (1993) Patients with bulimia nervosa who fail to engage in cognitive behavior therapy. Int J Eat Disord 13:35–40. https://doi.org/10.1002/1098-108x(199301)13:1%3c35::aid-eat2260130105%3e3.0.co;2-n

Preston GA, Marchant BK, Reimherr FW, Strong RE, Hedges DW (2004) Borderline personality disorder in patients with bipolar disorder and response to lamotrigine. J Affect Disord 79:297–303. https://doi.org/10.1016/S0165-0327(02)00358-0

Reich DB, Zanarini MC, Bieri KA (2009) A preliminary study of lamotrigine in the treatment of affective instability in borderline personality disorder. Int Clin Psychopharmacol 24:270–275. https://doi.org/10.1097/YIC.0b013e32832d6c2f

Crawford MJ, Sanatinia R, Barrett B, Cunningham G, Dale O, Ganguli P, Lawrence-Smith G, Leeson VC, Lemonsky F, Lykomitrou-Matthews G, Montgomery A, Morriss R, Munjiza J, Paton C, Skorodzien I, Singh V, Tan W, Tyrer P, Reilly JG (2018) Lamotrigine for people with borderline personality disorder: a RCT. Health Technol Assess Winch Engl 22:1–68. https://doi.org/10.3310/hta22170

Trunko ME, Schwartz TA, Marzola E, Klein AS, Kaye WH (2014) Lamotrigine use in patients with binge eating and purging, significant affect dysregulation, and poor impulse control. Int J Eat Disord 47:329–334. https://doi.org/10.1002/eat.22234

Trunko ME, Schwartz TA, Berner LA, Cusack A, Nakamura T, Bailer UF, Chen JY, Kaye WH (2017) A pilot open series of lamotrigine in DBT-treated eating disorders characterized by significant affective dysregulation and poor impulse control. Borderline Pers Disord Emot Dysregul 4:21. https://doi.org/10.1186/s40479-017-0072-6

Metropolitan Life Insurance Company (1957) New weight standards for men and women. Stat Bull 40:1–4

First M, Williams J, Karg R, Spitzer R (2015) Structured clinical interview for DSM-5—research version (SCID-5 for DSM-5, research version; SCID-5-RV). American Psychiatric Association, Arlington

Sheehan D, Lecrubier Y, Harnett Sheehan K, Janavs J, Weiller E, Keskiner A, Schinka J, Knapp E, Sheehan M, Dunbar G (1997) The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 12:232–241. https://doi.org/10.1016/S0924-9338(97)83297-X

Pfohl B, Blum N, St. John D, McCormick B, Allen J, Black DW (2009) Reliability and validity of the borderline evaluation of severity over time (BEST): a self-rated scale to measure severity and change in persons with borderline personality disorder. J Personal Disord 23:281–293. https://doi.org/10.1521/pedi.2009.23.3.281

Nock MK, Wedig MM, Holmberg EB, Hooley JM (2008) The emotion reactivity scale: development, evaluation, and relation to self-injurious thoughts and behaviors. Behav Ther 39:107–116. https://doi.org/10.1016/j.beth.2007.05.005

Lynam DR, Smith GT, Whiteside SA, Cynders MA (2006) The UPPS-P: assessing five personality pathways to impulsive behavior. West Lafayette Purdue Univ 10

Fairburn CG (2008) Cognitive behavior therapy and eating disorders. Guilford Press

Bates D, Mächler M, Bolker B, Walker S (2015) Fitting linear mixed-effects models using lme4. J Stat Softw 67:1–48. https://doi.org/10.18637/jss.v067.i01

Schaumberg K, Reilly EE, Anderson LM, Gorrell S, Wang SB, Sala M (2018) Improving prediction of eating-related behavioral outcomes with zero-sensitive regression models. Appetite 129:252–261. https://doi.org/10.1016/j.appet.2018.06.030

Bacaltchuk J, Hay P, Mari JJ (2000) Antidepressants versus placebo for the treatment of bulimia nervosa: a systematic review. Aust NZ J Psychiatry 34:310–317. https://doi.org/10.1080/j.1440-1614.2000.00709.x

Bacaltchuk J, Hay PP (2003) Antidepressants versus placebo for people with bulimia nervosa. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003391

Akingbala F, Dhanani N, Sherwood Brown E (2006) Impulsivity in patients with bipolar disorder and cocaine or amphetamine dependence given lamotrigine. J Dual Diagn 2:73–83. https://doi.org/10.1300/J374v02n03_07

Tritt K, Nickel C, Lahmann C, Leiberich PK, Rother WK, Loew TH, Nickel MK (2005) Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study. J Psychopharmacol (Oxf) 19:287–291. https://doi.org/10.1177/0269881105051540

Li X, Large CH, Ricci R, Taylor JJ, Nahas Z, Bohning DE, Morgan P, George MS (2011) Using interleaved transcranial magnetic stimulation/functional magnetic resonance imaging (fMRI) and dynamic causal modeling to understand the discrete circuit specific changes of medications: lamotrigine and valproic acid changes in motor or prefrontal effective connectivity. Psychiatry Res Neuroimaging 194:141–148. https://doi.org/10.1016/j.pscychresns.2011.04.012

Jogia J, Haldane M, Cobb A, Kumari V, Frangou S (2008) Pilot investigation of the changes in cortical activation during facial affect recognition with lamotrigine monotherapy in bipolar disorder. Br J Psychiatry 192:197–201. https://doi.org/10.1192/bjp.bp.107.037960